Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Chinese Patent Office
Boehringer Ingelheim
Covington
Moodys
Federal Trade Commission
Farmers Insurance
Cipla
QuintilesIMS

Generated: September 22, 2018

DrugPatentWatch Database Preview

AROMASIN Drug Profile

« Back to Dashboard

When do Aromasin patents expire, and when can generic versions of Aromasin launch?

Aromasin is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in AROMASIN is exemestane. There are fifteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the exemestane profile page.

Drug patent expirations by year for AROMASIN
Pharmacology for AROMASIN
Drug ClassAromatase Inhibitor
Mechanism of ActionAromatase Inhibitors
Synonyms for AROMASIN
(1S,2R,10R,11S,15S)-2,15-dimethyl-8-methylidenetetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadeca-3,6-diene-5,14-dione
(1S,2R,10R,11S,15S)-2,15-DIMETHYL-8-METHYLIDENETETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIENE-5,14-DIONE
(8alpha,10alpha,13alpha)-6-Methylideneandrosta-1,4-Diene-3,17-Dione
(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylene-7,8,9,10,11,12,13,14,15,16-decahydro-3H-cyclopenta[a]phenanthrene-3,17(6H)-dione
(8R,9S,10R,13S,14S)-10,13-Dimethyl-6-methylene-7,8,9,11,12,13,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17(10H,14H)-dione
(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione
(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione
107868-30-4
6-Methylen-androst-1,4-diene-3,17-dione
6-methylenandrost-1,4-dien-3,17-dione
6-Methylenandrosta-1,17-dione
6-Methylenandrosta-1,4-diene-3,17-dione
6-Methylene-androsta-1,4-diene-3,17-dione
6-Methyleneandrosta-1,4-diene-3,17-dione
6-methylideneandrosta-1,4-diene-3,17-dione
868E304
AB0063735
AB00639936_11
AB00639936-06
AB00639936-08
AB00639936-09
AB00639936-10
AC-2171
AC1L1SRB
AC1Q6AAZ
AJ-47550
AK-82825
AKOS015840113
AKOS015895161
Ambap107868-30-4
AN-6407
Androsta-1,4-diene-3,17-dione, 6-methylene-
ANW-63402
AOB5604
Aromasil
Aromasin (Pharmacia Upjohn)
Aromasin (TN)
Aromasin, Exemestane
Aromasine
BC666132
BCP0726000226
BCP9000676
BCPP000235
BDBM50398447
BFYIZQONLCFLEV-DAELLWKTSA-N
C-18573
C08162
CAS-107868-30-4
CC-28344
CCG-100995
CCRIS 9351
CHEBI:4953
CHEMBL1200374
CJ-11236
CPD000466314
CS-1766
CTK0H9416
Curator_000009
D00963
D0D2VS
DB00990
DSSTox_CID_3037
DSSTox_GSID_23037
DSSTox_RID_76844
DTXSID5023037
E0941
EXE
Exemestance
EXEMESTANE
Exemestane (JAN/USP/INN)
Exemestane [USAN:INN:BAN]
Exemestane for system suitability, European Pharmacopoeia (EP) Reference Standard
Exemestane, (pharmaceutical secondary standard; traceable to USP)
Exemestane, >=98% (HPLC)
Exemestane, Aromasin
Exemestane, European Pharmacopoeia (EP) Reference Standard
Exemestane, United States Pharmacopeia (USP) Reference Standard
Exemestane(FCE 24304)
Exemestano
Exemestano [INN-Spanish]
Exemestanum
Exemestanum [INN-Latin]
EXM
Fce 24304
FCE-24304
FCE24304
GTPL7073
HMS2051J04
HSDB 7463
HY-13632
KS-5136
LS-19329
MFCD00866994
MLS000759419
MLS001424062
NC00245
NCGC00095289-01
NCGC00271596-03
Nikidess
NSC-713563
NSC713563
NY22HMQ4BX
Pfizer brand of exemestane
PL005351
PNU 155971
PNU-155971
PubChem5810
s1196
SC-46568
SCHEMBL6215
SMR000466314
SY015689
SYN3023
TC-152147
Tox21_111499
Tox21_111499_1
UNII-NY22HMQ4BX
Z-4332
ZINC3973334

US Patents and Regulatory Information for AROMASIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn AROMASIN exemestane TABLET;ORAL 020753-001 Oct 21, 1999 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for AROMASIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn AROMASIN exemestane TABLET;ORAL 020753-001 Oct 21, 1999 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn AROMASIN exemestane TABLET;ORAL 020753-001 Oct 21, 1999 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Chinese Patent Office
Boehringer Ingelheim
Covington
Moodys
Federal Trade Commission
Farmers Insurance
Cipla
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.